Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Investor Presentation

Valiant Organics Investor Presentation: Key Takeaways

Valiant Organics presented its FY26 performance at the AGM, reporting Revenue of INR 739 Cr and EBITDA margin of 13.64%. The firm is shifting focus towards high-margin Benzene and Chlorophenol derivatives.

Highlights
Revenue growthFY26 revenue: INR 739 Cr (+2.8% YoY).
MarginsEBITDA margins improved from 8.59% (FY25) to 13.64% (FY26).
Demand visibilityStable demand from Dyes/Pigments (45%) and Pharma (21%).
Management confidenceHigh focus on integrated operations and import substitution.

Growth

FY26 revenue grew 2.8% YoY to INR 739 Cr; EBITDA rose significantly to INR 101 Cr vs INR 62 Cr.

Outlook

Operates 6 units with 80,000 TPA capacity. Focus remains on import substitution and maximizing output from existing 5 zero-liquid-discharge plants.

Risks

Historical revenue volatility and exposure to fluctuating chemical cycles across agrochemical and pharmaceutical end-user industries.

Source

Investor Presentation filed with BSE, NSE: VALIANTORG. Summary written with AI assistance from the document.

Read the document ↗

Valiant Organics Ltd: key numbers

Share price
₹456.20
Market cap
₹1,279 Cr
Revenue (annual)
₹738.8 Cr
Net profit (annual)
₹33.24 Cr
P/E (TTM)
23.6×Sector 34.1×
Promoter holding
37.89%+0.02% QoQ
FII holding
0.44%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Valiant Organics Ltd

All →